Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Takeda Pharmaceutical Co Ltd    4502   JP3463000004

TAKEDA PHARMACEUTICAL CO LTD (4502)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Financials (JPY)
Sales 2019 1 770 B
EBIT 2019 -
Net income 2019 159 B
Debt 2019 680 B
Yield 2019 4,01%
Sales 2020 1 822 B
EBIT 2020 -
Net income 2020 178 B
Debt 2020 541 B
Yield 2020 4,01%
P/E ratio 2019 22,03
P/E ratio 2020 19,66
EV / Sales2019 2,40x
EV / Sales2020 2,26x
Capitalization 3 571 B
More Financials
Company
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs.It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other.The Prescription Drugs segment includes the manufacture... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Takeda Pharmaceutical Co L
Trading Rating : Investor Rating :
More Ratings
Latest news on TAKEDA PHARMACEUTICAL CO L
06/21TAKEDA PHARMACEUTICAL : New Findings from Takeda Pharmaceutical Company in the A..
AQ
06/21TAKEDA PHARMACEUTICAL : Researchers' Work from Takeda Pharmaceutical Company Foc..
AQ
06/21TAKEDA PHARMACEUTICAL : Data on Gout Discussed by Researchers at Takeda Pharmace..
AQ
06/20TAKEDA PHARMACEUTICAL : Further Expands Help At Hand Patient Assistance Program ..
AQ
06/19TAKEDA PHARMACEUTICAL : Emulate raises $36M series C to improve Organ-Chips offe..
AQ
06/16International fund managers turn to financials, tech as trade worries rise
RE
06/14TAKEDA PHARMACEUTICAL : Researchers from Takeda Pharmaceutical Company Discuss F..
AQ
06/14TIGENIX : Takeda and TiGenix Announce Results of First Acceptance Period for the..
AQ
06/14NEW TYPE 2 DIABETES FINDINGS FROM TA : ...
AQ
06/12TAKEDA PHARMACEUTICAL : Announces Term Loan Credit Agreement and Amendment to Br..
AQ
More news
Sector news : Pharmaceuticals - NEC
05:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
01:38aRoche to Appoint James Sabry as Head of Partnering
DJ
06/21LONDON MARKETS: FTSE 100 Drops As Oil Shares Extend Losses; Pound Rallies On ..
DJ
06/20Canada sets October start for legal recreational marijuana sales
RE
06/20GILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
More sector news : Pharmaceuticals - NEC
Latest Tweets
06/21Barclays : Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD - AMENDMENT  
06/20Takeda Pharmaceutical's CEO weighs in on the future of China, cancer and Alzh..
11
06/20Barclays : Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD  
06/20GlobalData Plc - Takeda Pharmaceuticals USA Inc - Pharmaceuticals Healthcare .. 
06/20Shire : Form 8.3 - Takeda Pharmaceutical Company Limited  
More tweets
Qtime:30
News from SeekingAlpha
06/19Merger Arbitrage Mondays - June 18, 2018 
06/12Nash players perk up on Galmed surge 
06/12Can The Shire Buyout Be Stopped? 
06/08Translate Bio Could Be The Next Big Thing In Cystic Fibrosis 
06/08NASH players in spotlight on Bristol-Myers Squibb interest 
Chart TAKEDA PHARMACEUTICAL CO L
Duration : Period :
Takeda Pharmaceutical Co L Technical Analysis Chart | 4502 | JP3463000004 | 4-Traders
Technical analysis trends TAKEDA PHARMACEUTICAL CO L
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 6 261  JPY
Spread / Average Target 39%
EPS Revisions
Managers
NameTitle
Christophe Weber President, CEO & Representative Director
Costa Saroukos Chief Financial Officer
Andrew S. Plump Director, Chief Medical & Scientific Officer
Yasuhiko Yamanaka Managing Director & Head-Globalization
Masato Iwasaki Director & President-Japan Pharma Business Unit
Sector and Competitors
1st jan.Capitalization (M$)
TAKEDA PHARMACEUTICAL CO LTD-30.86%32 467
JOHNSON & JOHNSON-12.27%327 330
PFIZER0.00%213 275
NOVARTIS-10.87%189 575
ROCHE HOLDING LTD.-12.58%188 417
MERCK AND COMPANY8.90%164 862